WayPoint hits a rough “patch”
This article was originally published in The Tan Sheet
Executive Summary
FDA instructs WayPoint Biomedical Holdings to stop marketing and selling Health Essist Hangover-Free and Energy Boost Topical Patch products because the transdermal patches are unapproved drug delivery systems and the term "hangover" denotes a disease. The Huntington Beach, Calif.-based firm said June 3 it is permitted to sell the patches internationally. WayPoint added it is pursuing legal action to recover company shares issued to former President and Director Bret Hendzel, who was fired in February